Evaluation of the Role of Intravitreal Tissue Plasminogen Activator in Treatment of Refractory Diabetic Macular Edema

Sponsor
Mashhad University of Medical Sciences
Study ID
NCT01141881
Status
Terminated

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Purpose: to evaluate the effect of intravitreal injection of tissue plasminogen activator(tPA) in treatment of refractory diabetic macular edema(DME).

Key Dates

First listed
Jun 11, 2010
Start date
May 31, 2009
Status verified
Sep 2008
Primary completion
Jan 31, 2010
Completion
Mar 31, 2010

Study Design

Primary purpose
TREATMENT

Arms

  • Experimental: TPA,IVB,F/U

Related Studies